CRYOSITE LIMITED - Announcements

Market Cap $39.04M Add to my watchlist

Cryosite Limited is engaged in providing outsourced clinical trials depot services. The... Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

CTE	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	26/02/19		Share
CTE	Federal Court approves in principle settlement	PRICE SENSITIVE	13/02/19		Share
CTE	Cryosite reaches in principle settlement with ACCC	PRICE SENSITIVE	08/02/19		Share
CTE	Appendix4E and Annual report	PRICE SENSITIVE	30/08/18		Share
CTE	Trading Update	PRICE SENSITIVE	02/08/18		Share
CTE	ACCC proceedings	PRICE SENSITIVE	12/07/18	108.86KB	Share
CTE	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/02/18		Share
CTE	Appointment of CEO	PRICE SENSITIVE	17/01/18		Share
CTE	Cell Care transaction not to proceed. Meeting Cancelled	PRICE SENSITIVE	09/01/18		Share
CTE	ACCC ends review of Cell Care's Cryosite assets acquisition	PRICE SENSITIVE	21/12/17		Share
CTE	Trading update	PRICE SENSITIVE	22/11/17		Share
CTE	ACCC update	PRICE SENSITIVE	08/11/17		Share
CTE	Chairman's Address to Shareholders	PRICE SENSITIVE	03/11/17		Share
CTE	Appendix 4E and Annual Report	PRICE SENSITIVE	23/08/17		Share
CTE	ACCC review of proposed transaction of Cord Blood assets	PRICE SENSITIVE	04/08/17		Share
CTE	Cryosite to license its CB&T brand and sell certain assets	PRICE SENSITIVE	23/06/17		Share
CTE	Appointment of Interim CEO	PRICE SENSITIVE	15/06/17		Share
CTE	Resignation of CEO	PRICE SENSITIVE	19/05/17		Share
CTE	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	22/02/17		Share
CTE	Appendix 4E and audited annual report-CTE.AX	PRICE SENSITIVE	24/08/16		Share
CTE	Appointment of CEO-CTE.AX	PRICE SENSITIVE	08/06/16		Share
CTE	Appendix 4D and Half year accounts	PRICE SENSITIVE	24/02/16		Share
CTE	CEO resignation	PRICE SENSITIVE	03/09/15		Share
CTE	Appendix 4E and Annual Report	PRICE SENSITIVE	26/08/15		Share
CTE	Profit Guidance	PRICE SENSITIVE	29/05/15		Share
CTE	Appendix4D and Half Year Report and Accounts	PRICE SENSITIVE	25/02/15		Share
CTE	Appointment of CEO	PRICE SENSITIVE	20/01/15		Share
CTE	Results of Meeting	PRICE SENSITIVE	01/12/14		Share
CTE	Appendix 4e and Annual Report	PRICE SENSITIVE	28/08/14		Share
CTE +RGS	Cryosite Regeneus partnership	PRICE SENSITIVE	21/08/14		Share
CTE	Full year profit guidance update	PRICE SENSITIVE	13/06/14		Share
CTE	Retirement of Managing Director	PRICE SENSITIVE	07/04/14		Share
CTE	Appendix 4d Half Year Report and accounts	PRICE SENSITIVE	26/02/14		Share
CTE	2013-2014 profit guidance	PRICE SENSITIVE	23/12/13		Share
CTE	Dividend announcement - amendment to record date	PRICE SENSITIVE	02/09/13		Share
CTE	Dividend announcement	PRICE SENSITIVE	02/09/13		Share
CTE	Appendix 4E and Annual Financial Report	PRICE SENSITIVE	29/08/13		Share
CTE	CTE expands adult stem cell services	PRICE SENSITIVE	15/04/13		Share
CTE	Positive market guidance update	PRICE SENSITIVE	26/02/13		Share
CTE	Interim dividend Feb 2013	PRICE SENSITIVE	26/02/13		Share
CTE	App 4D and Half year accounts	PRICE SENSITIVE	26/02/13		Share
CTE	Cryosite Final Dividend	PRICE SENSITIVE	25/09/12		Share
CTE	Preliminary Final Report	PRICE SENSITIVE	23/08/12		Share
CTE	Collaboration with Regeneus	PRICE SENSITIVE	31/07/12		Share
CTE	Profit guidance	PRICE SENSITIVE	23/04/12		Share
CTE	Appendix 4d and Half year financial report	PRICE SENSITIVE	28/02/12		Share
CTE	ASX Price Query Response	PRICE SENSITIVE	15/11/11		Share
CTE	Appendix 4E and Full Year Statutory Accounts	PRICE SENSITIVE	22/08/11		Share
CTE +SPD	Sale of Cryosite Limited	PRICE SENSITIVE	09/06/11		Share
CTE	TGA licence extension	PRICE SENSITIVE	29/04/11		Share
CTE	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	23/02/11		Share
CTE	Appendix 4C - quarterly	PRICE SENSITIVE	14/01/11		Share
CTE	Appendix 4C - quarterly	PRICE SENSITIVE	21/10/10		Share
CTE	Full Year Statutory Accounts and appendix 4E	PRICE SENSITIVE	26/08/10		Share
CTE	Appendix 4C - quarterly	PRICE SENSITIVE	26/07/10		Share
CTE	Appendix 4C - quarterly	PRICE SENSITIVE	15/04/10		Share
CTE	Appendix 4d and Half year review financial statements	PRICE SENSITIVE	22/02/10		Share
CTE	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/10		Share
CTE	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/09		Share
CTE	Appendix 4E and Full Year Statutory Accounts	PRICE SENSITIVE	31/08/09		Share
CTE	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/09		Share
CTE	Appendix 4C - quarterly	PRICE SENSITIVE	24/04/09		Share
CTE	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	18/02/09		Share
CTE	Appendix 4C - quarterly	PRICE SENSITIVE	19/01/09		Share

CTE Appendix 4D and Half Year Accounts
26/02/19	PRICE SENSITIVE		Share
CTE Federal Court approves in principle settlement
13/02/19	PRICE SENSITIVE		Share
CTE Cryosite reaches in principle settlement with ACCC
08/02/19	PRICE SENSITIVE		Share
CTE Appendix4E and Annual report
30/08/18	PRICE SENSITIVE		Share
CTE Trading Update
02/08/18	PRICE SENSITIVE		Share
CTE ACCC proceedings
12/07/18	PRICE SENSITIVE	108.86KB	Share
CTE Appendix 4D and Half Year Report
28/02/18	PRICE SENSITIVE		Share
CTE Appointment of CEO
17/01/18	PRICE SENSITIVE		Share
CTE Cell Care transaction not to proceed. Meeting Cancelled
09/01/18	PRICE SENSITIVE		Share
CTE ACCC ends review of Cell Care's Cryosite assets acquisition
21/12/17	PRICE SENSITIVE		Share
CTE Trading update
22/11/17	PRICE SENSITIVE		Share
CTE ACCC update
08/11/17	PRICE SENSITIVE		Share
CTE Chairman's Address to Shareholders
03/11/17	PRICE SENSITIVE		Share
CTE Appendix 4E and Annual Report
23/08/17	PRICE SENSITIVE		Share
CTE ACCC review of proposed transaction of Cord Blood assets
04/08/17	PRICE SENSITIVE		Share
CTE Cryosite to license its CB&T brand and sell certain assets
23/06/17	PRICE SENSITIVE		Share
CTE Appointment of Interim CEO
15/06/17	PRICE SENSITIVE		Share
CTE Resignation of CEO
19/05/17	PRICE SENSITIVE		Share
CTE Appendix 4D and Half Year Accounts
22/02/17	PRICE SENSITIVE		Share
CTE Appendix 4E and audited annual report-CTE.AX
24/08/16	PRICE SENSITIVE		Share
CTE Appointment of CEO-CTE.AX
08/06/16	PRICE SENSITIVE		Share
CTE Appendix 4D and Half year accounts
24/02/16	PRICE SENSITIVE		Share
CTE CEO resignation
03/09/15	PRICE SENSITIVE		Share
CTE Appendix 4E and Annual Report
26/08/15	PRICE SENSITIVE		Share
CTE Profit Guidance
29/05/15	PRICE SENSITIVE		Share
CTE Appendix4D and Half Year Report and Accounts
25/02/15	PRICE SENSITIVE		Share
CTE Appointment of CEO
20/01/15	PRICE SENSITIVE		Share
CTE Results of Meeting
01/12/14	PRICE SENSITIVE		Share
CTE Appendix 4e and Annual Report
28/08/14	PRICE SENSITIVE		Share
CTE +RGS Cryosite Regeneus partnership
21/08/14	PRICE SENSITIVE		Share
CTE Full year profit guidance update
13/06/14	PRICE SENSITIVE		Share
CTERetirement of Managing Director
07/04/14	PRICE SENSITIVE		Share
CTEAppendix 4d Half Year Report and accounts
26/02/14	PRICE SENSITIVE		Share
CTE2013-2014 profit guidance
23/12/13	PRICE SENSITIVE		Share
CTEDividend announcement - amendment to record date
02/09/13	PRICE SENSITIVE		Share
CTEDividend announcement
02/09/13	PRICE SENSITIVE		Share
CTEAppendix 4E and Annual Financial Report
29/08/13	PRICE SENSITIVE		Share
CTECTE expands adult stem cell services
15/04/13	PRICE SENSITIVE		Share
CTEPositive market guidance update
26/02/13	PRICE SENSITIVE		Share
CTEInterim dividend Feb 2013
26/02/13	PRICE SENSITIVE		Share
CTEApp 4D and Half year accounts
26/02/13	PRICE SENSITIVE		Share
CTECryosite Final Dividend
25/09/12	PRICE SENSITIVE		Share
CTEPreliminary Final Report
23/08/12	PRICE SENSITIVE		Share
CTECollaboration with Regeneus
31/07/12	PRICE SENSITIVE		Share
CTEProfit guidance
23/04/12	PRICE SENSITIVE		Share
CTEAppendix 4d and Half year financial report
28/02/12	PRICE SENSITIVE		Share
CTEASX Price Query Response
15/11/11	PRICE SENSITIVE		Share
CTEAppendix 4E and Full Year Statutory Accounts
22/08/11	PRICE SENSITIVE		Share
CTE +SPDSale of Cryosite Limited
09/06/11	PRICE SENSITIVE		Share
CTETGA licence extension
29/04/11	PRICE SENSITIVE		Share
CTEAppendix 4D and Half Year Accounts
23/02/11	PRICE SENSITIVE		Share
CTEAppendix 4C - quarterly
14/01/11	PRICE SENSITIVE		Share
CTEAppendix 4C - quarterly
21/10/10	PRICE SENSITIVE		Share
CTEFull Year Statutory Accounts and appendix 4E
26/08/10	PRICE SENSITIVE		Share
CTEAppendix 4C - quarterly
26/07/10	PRICE SENSITIVE		Share
CTEAppendix 4C - quarterly
15/04/10	PRICE SENSITIVE		Share
CTEAppendix 4d and Half year review financial statements
22/02/10	PRICE SENSITIVE		Share
CTEAppendix 4C - quarterly
27/01/10	PRICE SENSITIVE		Share
CTEAppendix 4C - quarterly
29/10/09	PRICE SENSITIVE		Share
CTEAppendix 4E and Full Year Statutory Accounts
31/08/09	PRICE SENSITIVE		Share
CTEAppendix 4C - quarterly
31/07/09	PRICE SENSITIVE		Share
CTEAppendix 4C - quarterly
24/04/09	PRICE SENSITIVE		Share
CTEAppendix 4D and Half Year Accounts
18/02/09	PRICE SENSITIVE		Share
CTEAppendix 4C - quarterly
19/01/09	PRICE SENSITIVE		Share

REFRESH

(20min delay)
Last 85.0¢		Change 0.000(0.00%)		Mkt cap ! $39.04M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	630	80.0¢

Sellers (Offers)

Price($)	Vol.	No.
85.0¢	39	1

View Market Depth

No.	Vol.	Price($)
1	100000	0.036
1	48300	0.033
1	32290	0.030
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.098	135714	1
0.100	89416	1
0.120	45000	1
0.000	0	0
0.000	0	0

Last trade - 10.02am 04/12/2024 (20 minute delay)

CTE (ASX) Chart

Day chart unavailable